Abstract:Abstract: Objective To investigate the key targets of nobiletin in improving chronic rhinosinusitis with nasal polyps (CRSwNP) based on network pharmacology and to design experiments to verify them. Methods Nobiletin targets were screened by TCMSP, ETCM, CTD, HERB 2.0 and SymMap databases. CRSwNP targets were screened by GEO database. Differentially expressed genes and common targets were obtained by R package. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were performed on common targets. Cytoscape software was used to screen key targets. Molecular docking was verified by CB-Dock2 platform. CCK-8 method was used to detect the optimal non-toxic concentration of nobiletin on human nasal epithelial cells (HNEpC). LPS induced HNEpC was used to establish an inflammation model. ELISA was used to detect the levels of IL-6, IL-8, IL-1β and TNF-α. ROS kit was used to detect oxidative stress. Western blot was used to detect the expression of hypoxia-inducible factor-1α (HIF-1α) and heme oxygenase-1 (HMOX1). Results A total of 39 common targets were obtained. GO and KEGG analysis showed that they were mainly involved in HIF-1 signaling pathway, etc. MMP9, IL1β, TGFβ1, CXCL8, HMOX1 and CCK were screened as key targets by Cytoscape. Molecular docking showed that the binding energy of nobiletin and HMOX1 was -8.8kcal/mol. CCK-8 method determined that 80 μmol/L was the optimal non-toxic concentration. ELISA results showed that nobiletin could significantly reduce the levels of IL-6, IL-8, IL-1β and TNF-α. ROS detection showed that nobiletin could improve cellular oxidative stress. Western blot showed that nobiletin could downregulate the expression of HIF-1α and HMOX1 proteins. Conclusions Nobiletin can effectively inhibit LPS induced inflammatory response and oxidative stress damage in nasal epithelial cells. Nobiletin exerts anti-CRSwNP effects by binding to HMOX1 and inhibiting the HIF-1α/HMOX1 positive feedback loop, HMOX1 was identified as a potential key target.